TMPRSS6基因的突变会导致铁难治性缺铁性贫血(IRIDA)。
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
作者信息
Finberg Karin E, Heeney Matthew M, Campagna Dean R, Aydinok Yeşim, Pearson Howard A, Hartman Kip R, Mayo Mary M, Samuel Stewart M, Strouse John J, Markianos Kyriacos, Andrews Nancy C, Fleming Mark D
机构信息
Pathology Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
出版信息
Nat Genet. 2008 May;40(5):569-71. doi: 10.1038/ng.130. Epub 2008 Apr 13.
Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.
缺铁通常归因于慢性失血或饮食摄入不足。在此,我们表明,口服铁剂治疗无效的缺铁性贫血可能由TMPRSS6基因的种系突变引起,该基因编码一种由肝脏产生的II型跨膜丝氨酸蛋白酶,可调节全身铁调节激素铁调素的表达。这些发现表明,TMPRSS6对人类正常的全身铁稳态至关重要。